SOSLAB’s LiDAR ‘ML’ for Automotive Wins CES Innovation Award
12.1.2021 16:00:00 EET | Business Wire | Press release
SOSLAB that specializes in LiDAR, won the CES 2021 Innovation Awards at the world's largest electronics exhibition 'CES 2021,' for its Solid-state LiDAR ‘ML’ for automotive.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210112005486/en/
Professional LiDAR Sensor provider SOSLAB won the CES 2021 Innovation Awards for its Solid-state LiDAR ML for automotive. The Solid-state LiDAR ML for autonomous vehicles won the Innovation Awards in the Vehicle Intelligence and Transportation category. This award recognizes the excellence of this product ML: Compact LiDAR without moving parts inside which enables simpler vehicle sensor deployment in terms of size, weight and stability. ML is easy to mass-produce with a simple structural design which is expected to attract attention in the automotive LiDAR market. ML will be supplied to strategic partners only, launching prototype products in the global market at CES 2021. More information on ML can be found at the SOSLAB booth at the CES 2021 exhibition held online from January 11th to 14th. (Photo: Business Wire)
The CES Innovation Awards are awarded by about 50 expert judges who select the most innovative products in 28 categories each year. The products selected for this innovation award are displayed at the CES Innovation Showcase from January 11th.
SOSLAB’s Solid-state LiDAR ‘ML’ for autonomous vehicles won the Innovation Awards in the Vehicle Intelligence & Transportation category. This award recognizes the excellence of this product ML: Compact LiDAR without moving parts inside which enables simpler vehicle sensor deployment in terms of size, weight and stability.
The mechanical type of LiDAR currently used for research on autonomous driving has a limitation in mass production due to the system complexity caused by the moving components; ML is easy to mass-produce with a simple structural design which is expected to attract attention in the automotive LiDAR market.
ML was previously unveiled at KES2020 held at the COEX Exhibition Hall last year and will be supplied to strategic partners only, launching prototype products in the global market at CES 2021. More information on ML can be found at the SOSLAB booth at the CES 2021 exhibition held online from January 11th to 14th.
SOSLAB’s CEO, Jiseong Jeong said, “SOSLAB will become a company that makes the world smarter with LiDAR. Along with the verification of ML's technical excellence, we plan to complete product performance verification and auto-grade qualification by the second half of this year by securing additional capital with the goal of mass production of Solid-state LiDARs in 2022. SOSLAB will grow into a company that leads the global LiDAR market by commercializing LiDAR for vehicles.”
See SOSLAB's Compact 3D Solid-state LiDAR ‘ML’ video on
https://youtu.be/o3hSOnNKlDw
Additional Info.
Website:
http://soslab.co/
YouTube:
https://www.youtube.com/soslab
About SOSLAB
SOSLAB specializes in LiDAR (Light Detection and Ranging), which measures the distance to an object using light. We develop and supply 2D and 3D LiDARs to the market, growing into a global company by successfully developing Solid-state LiDAR for automotive.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210112005486/en/
Contact information
SOSLAB
Ellie Yeojin Kim / Marketing Manager
+82-62-973-5051
ellie.kim@soslab.co
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces the European Commission Approval of Zynyz ® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 23:42:00 EET | Press release
Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meury, President and Chief Executive Officer, Incyte. “As the first PD-1 immunotherapy approved in Europe in combination with platinum-based chemotherapy in the first-line setting, Zynyz helps expand the standard-of-care options available to clinicians and underscores our commitment to delivering innovative medicines that can have an impact for patients.” The EC decision follows the January 2026 positive opinion received from the European Medicines Agency’s Committee f
Dfns Launches Payouts6.3.2026 22:27:00 EET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 21:23:00 EET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 19:30:00 EET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
Sutherland Launches FinAI Hub to Industrialize Agentic AI for Banking and Financial Services6.3.2026 15:00:00 EET | Press release
Today, Sutherland announced the launch of Sutherland FinAI Hub, an enterprise Agentic AI platform built exclusively for Banking and Financial Services. As financial institutions accelerate AI adoption, many initiatives remain confined to pilots, unable to scale across legacy systems and core operations. Sutherland FinAI Hub is designed to help close that gap. FinAI Hub is an innovation ecosystem where Sutherland works with clients to design, prototype, and scale Agentic AI workflows across core operations. At launch, the platform brings together a large and expanding workforce of domain-trained AI agents purpose-built for financial institutions, supporting functions across retail banking, payments, cards, consumer and commercial lending, servicing, back office, risk and compliance functions. These modular agents can operate independently or be orchestrated across end-to-end workflows spanning onboarding, KYC, AML, fraud, underwriting, payments, disputes, servicing, and collections. For
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom